Free Trial

OncoCyte (OCX) Stock Chart & Stock Price History

OncoCyte logo
$3.73 +0.54 (+16.96%)
As of 01:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OncoCyte Stock Price Performance

5 Day
Performance
+22.86%
1 Month
Performance
+59.26%
3 Month
Performance
+49.57%
6 Month
Performance
+12.79%
Year-To-Date
Performance
+44.54%
1 Year
Performance
+13.91%
Receive OCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter.

OCX Stock Chart for Wednesday, March, 5, 2025

OncoCyte Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
03/04/2025$2.78$3.19
+14.75%
$3.19$2.63105,518 shs$55.68 million
03/03/2025$2.80$2.78
-0.71%
$2.85$2.60175,481 shs$48.52 million
02/28/2025$2.57$2.80
+8.95%
$2.80$2.52179,389 shs$48.87 million
02/27/2025$2.57$2.57$2.60$2.5145,334 shs$44.85 million
02/26/2025$2.52$2.57
+1.98%
$2.70$2.5122,624 shs$44.85 million
02/25/2025$2.63$2.52
-4.18%
$2.60$2.3247,920 shs$43.97 million
02/24/2025$2.65$2.63
-0.75%
$2.68$2.5722,329 shs$45.89 million
02/21/2025$2.72$2.65
-2.57%
$2.79$2.5751,737 shs$46.24 million
02/20/2025$2.76$2.72
-1.45%
$2.85$2.6148,208 shs$47.46 million
02/19/2025$2.70$2.76
+2.22%
$2.84$2.7197,046 shs$48.16 million
02/18/2025$2.56$2.70
+5.47%
$2.80$2.51107,528 shs$45.44 million
02/17/2025$2.56$2.56$2.57$2.3573,907 shs$44.68 million
02/14/2025$2.38$2.56
+7.56%
$2.57$2.3573,907 shs$43.09 million
02/13/2025$2.51$2.38
-5.18%
$2.49$2.21120,921 shs$41.54 million
02/12/2025$2.37$2.51
+5.91%
$2.60$2.30226,614 shs$42.24 million
02/11/2025$2.07$2.37
+14.49%
$2.58$2.07362,186 shs$39.89 million
02/10/2025$2.01$2.07
+2.99%
$2.12$1.9741,876 shs$34.84 million
02/07/2025$2.05$2.01
-1.95%
$2.17$1.9535,367 shs$33.83 million
02/06/2025$2.16$2.05
-5.09%
$2.13$2.0516,472 shs$34.50 million
02/05/2025$2.13$2.16
+1.41%
$2.18$2.0720,808 shs$36.35 million
02/04/2025$2.13$2.13$2.29$2.0639,801 shs$35.85 million

This page (NASDAQ:OCX) was last updated on 3/5/2025 by MarketBeat.com Staff
From Our Partners